|
1
|
Jeng KS, Sheen IS, Jeng WJ, et al: High
expression of Sonic Hedgehog signaling pathway genes indicates a
risk of recurrence of breast carcinoma. Onco Targets Ther. 7:79–86.
2013.
|
|
2
|
Binaschi M, Capranico G, Dal Bo L and
Zunino F: Relationship between lethal effects and topoisomerase
II-mediated double-stranded DNA breaks produced by anthracyclines
with different sequence specificity. Mol Pharmacol. 51:1053–1059.
1997.
|
|
3
|
Violet JA and Harmer C: Breast cancer:
improving outcome following adjuvant radiotherapy. Br J Radiol.
77:811–820. 2004.
|
|
4
|
Valerie K and Povirk LF: Regulation and
mechanisms of mammalian double-strand break repair. Oncogene.
22:5792–5812. 2003.
|
|
5
|
Lavin MF: Ataxia-telangiectasia: from a
rare disorder to a paradigm for cell signalling and cancer. Nat Rev
Mol Cell Biol. 9:759–769. 2008.
|
|
6
|
Hickson I, Zhao Y, Richardson CJ, et al:
Identification and characterization of a novel and specific
inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer
Res. 64:9152–9159. 2004.
|
|
7
|
Ramachandran S, Tran DD, Klebba-Faerber S,
et al: An ataxia-telangiectasia-mutated (ATM) kinase mediated
response to DNA damage down-regulates the mRNA-binding potential of
THOC5. RNA. 17:1957–1966. 2011.
|
|
8
|
Helleday T, Petermann E, Lundin C, et al:
DNA repair pathways as targets for cancer therapy. Nat Rev Cancer.
8:193–204. 2008.
|
|
9
|
Golding SE, Rosenberg E, Valerie N, et al:
Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma
cells, compromises insulin, AKT and ERK prosurvival signaling, and
inhibits migration and invasion. Mol Cancer Ther. 8:2894–2902.
2009.
|
|
10
|
Saito S, Goodarzi AA, Higashimoto Y, et
al: ATM mediates phosphorylation at multiple p53 sites, including
Ser(46), in response to ionizing radiation. J Biol Chem.
277:12491–12494. 2002.
|
|
11
|
Saito S, Yamaguchi H, Higashimoto Y, et
al: Phosphorylation site interdependence of human p53
post-translational modifications in response to stress. J Biol
Chem. 278:37536–37544. 2003.
|
|
12
|
Park BK, Zeng X and Glazer RI: Akt1
induces extracellular matrix invasion and matrix
metalloproteinase-2 activity in mouse mammary epithelial cells.
Cancer Res. 61:7647–7653. 2001.
|
|
13
|
Kim D, Kim S, Koh H, et al: Akt/PKB
promotes cancer cell invasion via increased motility and
metalloproteinase production. FASEB J. 15:1953–1962. 2001.
|
|
14
|
Tanno S, Tanno S, Mitsuuchi Y, et al: AKT
activation up-regulates insulin-like growth factor I receptor
expression and promotes invasiveness of human pancreatic cancer
cells. Cancer Res. 61:589–593. 2001.
|
|
15
|
Arboleda MJ, Lyons JF, Kabbinavar FF, et
al: Overexpression of AKT2/protein kinase Bbeta leads to
up-regulation of beta1 integrins, increased invasion, and
metastasis of human breast and ovarian cancer cells. Cancer Res.
63:196–206. 2003.
|
|
16
|
Grille SJ, Bellacosa A, Upson J, et al:
The protein kinase Akt induces epithelial mesenchymal transition
and promotes enhanced motility and invasiveness of squamous cell
carcinoma lines. Cancer Res. 63:2172–2178. 2003.
|
|
17
|
Andjelković M, Alessi DR, Meier R, et al:
Role of translocation in the activation and function of protein
kinase B. J Biol Chem. 272:31515–31524. 1997.
|
|
18
|
Bellacosa A, Chan TO, Ahmed NN, et al: Akt
activation by growth factors is a multiple-step process: the role
of the PH domain. Oncogene. 17:313–325. 1998.
|
|
19
|
Hazan RB, Phillips GR, Qiao RF, et al:
Exogenous expression of N-cadherin in breast cancer cells induces
cell migration, invasion, and metastasis. J Cell Biol. 148:779–790.
2000.
|
|
20
|
Ciciarello M, Mangiacasale R, Casenghi M,
et al: p53 displacement from centrosomes and p53-mediated G1 arrest
following transient inhibition of the mitotic spindle. J Biol Chem.
276:19205–19213. 2001.
|
|
21
|
Zhang T, Tan Y, Zhao R and Liu Z: DNA
damage induced by oridonin involves cell cycle arrest at G2/M phase
in human MCF-7 cells. Contemp Oncol (Pozn). 17:38–44. 2013.
|
|
22
|
Abraham RT: Cell cycle checkpoint
signaling through the ATM and ATR kinases. Genes Dev. 15:2177–2196.
2001.
|
